~~<i id='795634F95B'><strike id='795634F95B'><tt id='795634F95B'><pre id='795634F95B'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：leisure time 2025-09-27 09:34:09 Page View：79

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： WHO may add ‘noma' to its list of neglected tropical diseases
Next article： ChatGPT in medicine: STAT answers readers' burning questions

knowledge

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

Traditional Chinese medicine benefits explored in new JAMA study

STR/AFPviaGettyImagesAtraditionalChinesemedicinecompoundusedforcardiacbenefitsmighthelpreducetheinci

Cancer drug shortages should be causing more outrage

DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

Emergency medicine has repudiated 'excited delirium.' Now what?

AdobeGeorgeFloyd.AngeloQuinto.ElijahMcClain.Allthreemenwerekilledbylethalforceinflictedbythepolice,a